Last reviewed · How we verify
NCT02978521
Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients
NA trial testing Pulmonary rehabilitation in Pulmonary Rehabilitation in 94 participants. Currently enrolling.
5 December 2026
Quick facts
| Lead sponsor | Instituto Nacional de Cancerologia de Mexico |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 94 |
| Start date | 5 August 2016 |
| Primary completion | 5 December 2026 |
| Estimated completion | 12 December 2027 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Pulmonary rehabilitation
Conditions studied
- Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
- Sarcopenia — all drugs for Sarcopenia →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Instituto Nacional de Cancerologia de Mexico — full company profile →
Who can join
Adults 18 to 70, any sex, with Pulmonary Rehabilitation or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lung cancer (LC) is usually diagnosed in advanced stages and continues to be the leading cause of cancer related deaths worldwide. Cancer cachexia are frequent among patients with LC affecting up to 80% of patients with advanced stage disease, and it has been related with higher risk of complications, length of hospital stay, and worst overall survival. During cancer cachexia, both muscle and fat mass can be wasted, however, the loss of muscle mass has been associated to higher treatment related toxicity, loss of functional status, shorter progression free survival and overall survival in different types of cancer under various treatments. Hence, preservation of muscle mass and function should be an important focus of the multidisciplinary treatment of patients with LC. Pulmonary rehabilitation (PR) has been known to improve pulmonary function, reduce fatigue and improve exercise tolerance in patients with LC undergoing curative surgery. However, few studies have focused on the efficacy of PR on patients with advanced cancer undergoing palliative care with chemotherapy or targeted therapies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
Avancini A, Sartori G, Gkountakos A, Casali M, et al · · 2020 · cited 120× · PMID 32162811 · DOI 10.1634/theoncologist.2019-0463
Verify or expand the search:
- PubMed search for NCT02978521
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary rehabilitation
Trials testing the same drug.
- NCT07088185 — Pulmonary Outcomes on Patients With Lung Fibrosis · NA · active not recruiting
- NCT06522724 — Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19 · NA · completed
- NCT06366113 — Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) · NA · recruiting
- NCT06028711 — Education Impact on Rehabilitation of Hospitalized Patients with Chronic Obstructive Pulmonary Disease. · NA · completed
- NCT06051136 — Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer · NA · active not recruiting
Other recruiting trials for Pulmonary Rehabilitation
Currently open trials in the same condition.
- NCT07430943 — Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation · NA · recruiting
- NCT07185178 — Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS · NA · recruiting
- NCT07061444 — Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients · NA · recruiting
- NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
- NCT07195838 — Mindful-Breath for People With COPD · NA · recruiting
Other Instituto Nacional de Cancerologia de Mexico trials
Trials by the same sponsor.
- NCT06422533 — Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients · NA · recruiting
- NCT06477302 — Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer · recruiting
- NCT06090747 — Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. · NA · recruiting
- NCT06238882 — Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. · NA · recruiting
- NCT06883409 — Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02978521 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Cancerologia de Mexico
- Last refreshed: 8 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02978521.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing